Available Clinical Trials

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355). E-mail: askroswell@roswellpark.org
 

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Principal Investigator: Li, Qiang J
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
Principal Investigator: Zsiros, Emese
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Principal Investigator: Malek, Ehsan
Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)
Principal Investigator: Smith, Danielle M
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Principal Investigator: Jain, Prantesh
Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing
Principal Investigator: Sheffer, Christine E
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Principal Investigator: Chatta, Gurkamal S
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Principal Investigator: Kelly, Kara M
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Principal Investigator: Thanikachalam, Kannan
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Principal Investigator: Levine, Ellis G
A Phase 1, Study of BMF-500 in Adults With Acute Leukemia
Principal Investigator: Wang, Eunice S
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects
Principal Investigator: O'Connor, Richard J
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Principal Investigator: Twist, Clare J
Study to Assess SLN124 in Patients With Polycythemia Vera
Principal Investigator: Green, Steven D
A Food Security Intervention for the Prevention of Cancer in Low-income Families
Principal Investigator: Yeary, Karen H
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs (IGNYTE-3)
Principal Investigator: Wong, Michael K
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of BMS-986393 in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Principal Investigator: Malek, Ehsan
Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma
Principal Investigator: Krishnamurthy, Anuradha
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
Principal Investigator: O'Connor, Richard J
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Principal Investigator: Kabraji, Sheheryar K
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
Principal Investigator: Gupta, Ajay
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Principal Investigator: Barth, Matthew J
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
Principal Investigator: Zsiros, Emese
A Phase 1 Study of ADI-001 in Autoimmune Disease
Principal Investigator: Holtan, Shernan G
SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers
Principal Investigator: Kabraji, Sheheryar K